| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.7M | -48.9% |
| SG&A Expense | $8.5M | +7.6% |
| Operating Income | -$20.2M | +34.4% |
| Pre-tax Income | -$19.8M | +33.6% |
| Income Tax | $19K | -3.2% |
| Net Income | -$19.9M | +33.6% |
| EPS (Basic) | -$5.48 | -508.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.4M | +7.1% |
| Current Assets | $15.1M | +2.9% |
| Total Assets | $15.9M | +2.7% |
| Current Liabilities | $7.3M | -50.2% |
| Total Liabilities | $7.3M | -50.5% |
| Stockholders' Equity | $8.6M | +964.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.6M | +26.7% |
| Financing Cash Flow | $25.6M | +8.1% |